Discover the world of Recursive Self-Improvement (RSI) in AI. From I.J. Good's intelligence explosion to modern self-healing code and clinical applications, explore who is developing it, how it works, ...

Founded by former Google DeepMind scientists, Poetiq emerges from "stealth" after setting a new state-of-the-art (SOTA) on ...

When Apple released iOS 26 back in September, many iPhone users were eager to try its new customizations, features, and security updates. But, as with major software transitions, the launch hasn't ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Researchers at TU Wien have discovered an unexpected connection between two very different areas of artificial intelligence: Large Language Models (LLMs) can help solve logical problems—without ...

The best way to fix Americans’ cost-of-living problem is to give workers bigger raises, Federal Reserve Chair Jerome Powell said last week. The problem: That solution looks broken, too. The US job ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. Before market open, ...

President Donald Trump has a fresh chance this week to act on a priority voters continually say they want fixed — but over which he’s in denial. The high and rising prices of health care, groceries ...